Feasibility study of synthetic ghrelin as a treatment for acute pulmonary complications of patients with esophageal carcinoma who undergo subtotal esophagectomy

Feasibility study of synthetic ghrelin as a treatment for acute pulmonary complications of patients with esophageal carcinoma who undergo subtotal esophagectomy - Feasibility study of synthetic ghrelin as a treatment for acute pulmonary complications of patients with subtotal esophagectomy

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026115

Enrollment

Registered

2017-02-14

Start date

2017-02-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thoracic esophageal cancer

Interventions

at the same time at the same time at the same time

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. thoracic esophageal cancer

Exclusion criteria

Exclusion criteria: 1. invasion

Design outcomes

Primary

Measure	Time frame
the level of IL-6 concentration in the blood at POD3	—

Secondary

Measure	Time frame
pulmonary complications, duration of SIRS (systemic inflammatory response syndrome), the level of CRP, the level of IL-6 at POD1, 5, 7 and adverse events	—

Countries

Japan

Contacts

Public ContactMiyazaki Yasuhiro

Osaka University Hospital Department of Gastroenterological Surgery

ymiyazaki@gesurg.med.osaka-u.ac.jp06-6879-3251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026